Healthcare provider profile · identity verified

Kerwin Yap, NP

Nurse Practitioner · LAS VEGAS, NV · NPI 1386916831

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	385	69
Amlodipine Besylate	Amlodipine Besylate	372	69
Atorvastatin Calcium	Atorvastatin Calcium	365	79
Ibuprofen	Ibuprofen	309	54
Omeprazole	Omeprazole	268	47
Lisinopril	Lisinopril	241	51
Levothyroxine Sodium	Levothyroxine Sodium	226	42
Furosemide	Furosemide	216	40
Metformin Hcl	Metformin Hcl	207	40
Metoprolol Tartrate	Metoprolol Tartrate	195	41
Famotidine	Famotidine	191	30
Pantoprazole Sodium	Pantoprazole Sodium	168	30
Albuterol Sulfate Hfa	Albuterol Sulfate	162	38
Clonidine Hcl	Clonidine Hcl	161	29
Losartan Potassium	Losartan Potassium	156	39
Tamsulosin Hcl	Tamsulosin Hcl	151	25
Hydrochlorothiazide	Hydrochlorothiazide	146	30
Clopidogrel	Clopidogrel Bisulfate	135	21
Meclizine Hcl	Meclizine Hcl	134	23
Donepezil Hcl	Donepezil Hcl	127	24
Potassium Chloride	Potassium Chloride	120	22
Baclofen	Baclofen	117	17
Trazodone Hcl	Trazodone Hcl	117	20
Diclofenac Sodium	Diclofenac Sodium	114	38
Fenofibrate	Fenofibrate Nanocrystallized	111	21
Ventolin Hfa	Albuterol Sulfate	98	21
Alcohol Pads	Alcohol Antiseptic Pads	97	20
Fluticasone Propionate	Fluticasone Propionate	97	20
Nitroglycerin	Nitroglycerin	95	16
Rosuvastatin Calcium	Rosuvastatin Calcium	93	18
Quetiapine Fumarate	Quetiapine Fumarate	86	17
Ozempic	Semaglutide	85	16
Acetaminophen-Codeine	Acetaminophen With Codeine	82	14
Triamcinolone Acetonide	Triamcinolone Acetonide	82	12
Lidocaine	Lidocaine	80	21
Glipizide	Glipizide	78	21
Naproxen	Naproxen	74	16
Allopurinol	Allopurinol	73	suppressed
Eliquis	Apixaban	73	16
Azithromycin	Azithromycin	67	47
Carvedilol	Carvedilol	66	18
Amoxicillin	Amoxicillin	64	35
Alendronate Sodium	Alendronate Sodium	63	11
Ezetimibe	Ezetimibe	61	suppressed
Duloxetine Hcl	Duloxetine Hcl	60	12
Finasteride	Finasteride	60	suppressed
Sucralfate	Sucralfate	60	suppressed
Hydralazine Hcl	Hydralazine Hcl	59	suppressed
Linzess	Linaclotide	59	12
Alprazolam	Alprazolam	58	13
Escitalopram Oxalate	Escitalopram Oxalate	57	12
Fenofibrate	Fenofibrate	57	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	11
Montelukast Sodium	Montelukast Sodium	56	13
Zolpidem Tartrate	Zolpidem Tartrate	53	12
Simvastatin	Simvastatin	51	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	49	17
Mirtazapine	Mirtazapine	48	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	47	suppressed
Tizanidine Hcl	Tizanidine Hcl	47	12
Oxybutynin Chloride Er	Oxybutynin Chloride	46	11
Tramadol Hcl	Tramadol Hcl	46	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	13
Dicyclomine Hcl	Dicyclomine Hcl	44	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	44	39
Metoprolol Succinate	Metoprolol Succinate	42	suppressed
Ondansetron Odt	Ondansetron	42	suppressed
Ranolazine Er	Ranolazine	42	suppressed
Sertraline Hcl	Sertraline Hcl	42	suppressed
Breo Ellipta	Fluticasone/Vilanterol	41	suppressed
Januvia	Sitagliptin Phosphate	41	11
Memantine Hcl	Memantine Hcl	41	suppressed
Jardiance	Empagliflozin	39	suppressed
Hydrocortisone	Hydrocortisone	37	13
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Methocarbamol	Methocarbamol	36	suppressed
Farxiga	Dapagliflozin Propanediol	34	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Prednisone	Prednisone	31	13
Propranolol Hcl	Propranolol Hcl	30	suppressed
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Ketoconazole	Ketoconazole	29	suppressed
Meloxicam	Meloxicam	29	suppressed
Memantine Hcl Er	Memantine Hcl	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	28	suppressed
Megestrol Acetate	Megestrol Acetate	28	suppressed
Tradjenta	Linagliptin	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Colchicine	Colchicine	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	20
Metoclopramide Hcl	Metoclopramide Hcl	26	suppressed
Mupirocin	Mupirocin	26	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Promethazine Hcl	Promethazine Hcl	24	12
Alcohol Prep Pads	Alcohol Antiseptic Pads	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	20
Glimepiride	Glimepiride	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Vascepa	Icosapent Ethyl	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	17
Diazepam	Diazepam	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Repatha Sureclick	Evolocumab	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Valsartan	Valsartan	21	suppressed
Atenolol	Atenolol	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	19	suppressed
Fluconazole	Fluconazole	19	11
Acyclovir	Acyclovir	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Rivastigmine	Rivastigmine	18	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	17	suppressed
Brilinta	Ticagrelor	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	16	suppressed
Methimazole	Methimazole	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Epinephrine	Epinephrine	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Repatha Syringe	Evolocumab	15	suppressed
Sure Comfort Alcohol	Alcohol Antiseptic Pads	15	suppressed
Topiramate	Topiramate	15	suppressed
Torsemide	Torsemide	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Primidone	Primidone	14	suppressed
Quinidine Sulfate	Quinidine Sulfate	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Temazepam	Temazepam	13	suppressed
Captopril	Captopril	12	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	12	suppressed
Fluocinonide	Fluocinonide	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nexium	Esomeprazole Magnesium	12	suppressed
Novolin N	Insulin Nph Human Isophane	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error